Document Detail


L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
MedLine Citation:
PMID:  16378695     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objective of the study was to assess l-5-hydroxytryptophan's (l-5HTP) augmentation effect on the neuroendocrine response to a SSRI (citalopram). A neuroendocrine challenge study was conducted in healthy Asian male subjects. The neuroendocrine response to oral citalopram and l-5HTP was measured primarily as the prolactin and cortisol area under the response curve (or AUC). The study comprised 2 studies: Study 1. A double blind, randomised dose ranging study was conducted with l-5HTP (50-200 mg) to explore the prolactin and/or cortisol dose response and select a dose that provided a threshold neuroendocrine response. Study 2. A randomized comparison of citalopram 20 vs 40 mg was used to assess the effect of these doses on prolactin and cortisol. Based on the results of the dose response assessments with l-5HTP and cortisol, 200 mg l-5HTP was subsequently used in Study 2 to explore the augmentation of the neuroendocrine response to 20 mg citalopram. Citalopram, but not l-5HTP, increased prolactin AUC(0-3h) while 5HTP and citalopram increased cortisol AUC(0-3h). A 200 mg dose of l-5HTP significantly augmented the prolactin and cortisol response AUC(0-3h) to 20mg oral citalopram. The results of the study suggest that an augmented neuroendocrine challenge may be a suitable marker to demonstrate increased 5-HT-mediated responses when exploring novel agents as improved SSRIs.
Authors:
Stephen L Lowe; Kwee Poo Yeo; Leyan Teng; Danny K W Soon; Alan Pan; Stephen D Wise; Richard W Peck
Related Documents :
16364545 - Effects of fluoxetine on cellular immune response in stressed mice.
10510145 - Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline-...
14660035 - Emetic action of the prostanoid tp receptor agonist, u46619, in suncus murinus (house m...
17348765 - Translating the evidence on atypical depression into clinical practice.
12021095 - Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of ...
11902265 - Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainl...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2005-12-27
Journal Detail:
Title:  Psychoneuroendocrinology     Volume:  31     ISSN:  0306-4530     ISO Abbreviation:  Psychoneuroendocrinology     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-03-14     Completed Date:  2006-06-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7612148     Medline TA:  Psychoneuroendocrinology     Country:  England    
Other Details:
Languages:  eng     Pagination:  473-84     Citation Subset:  IM    
Affiliation:
Lilly-NUS Centre for Clinical Pharmacology, Level 6, Clinical Research Centre (MD11), National University of Singapore, 10 Medical Drive, Singapore, Singapore 117597. lowe-stephen@lilly.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5-Hydroxytryptophan / physiology*
Adult
Area Under Curve
Citalopram / pharmacology*
Dose-Response Relationship, Drug
Double-Blind Method
Humans
Hydrocortisone / blood*
Male
Middle Aged
Neurosecretory Systems / drug effects
Prolactin / blood*,  drug effects
Reference Values
Serotonin Uptake Inhibitors / pharmacology*
Chemical
Reg. No./Substance:
0/Serotonin Uptake Inhibitors; 50-23-7/Hydrocortisone; 56-69-9/5-Hydroxytryptophan; 59729-33-8/Citalopram; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presynaptic GABAA receptors facilitate spontaneous glutamate release from presynaptic terminals on m...
Next Document:  Relationship between pretreatment laboratory-measured episodes of reactive hypoglycemia and short-te...